Simplex Trading’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-18,857
| Closed | -$270K | – | 9413 |
|
|
2025
Q4 | $269K | Buy |
+18,857
| New | +$185K | ﹤0.01% | 3930 |
|
|
2025
Q3 | – | Sell |
-5,210
| Closed | -$37.1K | – | 9366 |
|
|
2025
Q2 | $29K | Sell |
5,210
-59,404
| -92% | -$383K | ﹤0.01% | 6426 |
|
|
2025
Q1 | $527K | Buy |
64,614
+53,957
| +506% | +$499K | ﹤0.01% | 3345 |
|
|
2024
Q4 | $100K | Sell |
10,657
-9,593
| -47% | -$99.7K | ﹤0.01% | 5171 |
|
|
2024
Q3 | $216K | Sell |
20,250
-54,345
| -73% | -$592K | ﹤0.01% | 4441 |
|
|
2024
Q2 | $739K | Buy |
74,595
+49,610
| +199% | +$509K | ﹤0.01% | 3240 |
|
|
2024
Q1 | $294K | Sell |
24,985
-227,004
| -90% | -$2.9M | ﹤0.01% | 4416 |
|
|
2023
Q4 | $3.58M | Buy |
251,989
+220,670
| +705% | +$2.51M | ﹤0.01% | 1842 |
|
|
2023
Q3 | $380K | Buy |
+31,319
| New | +$404K | ﹤0.01% | 3688 |
|
|
2022
Q4 | – | Sell |
-12,376
| Closed | -$139K | – | 9553 |
|
|
2022
Q3 | $129K | Buy |
+12,376
| New | +$138K | ﹤0.01% | 5182 |
|
|
2022
Q2 | – | Sell |
-1,788
| Closed | -$14.7K | – | 10301 |
|
|
2022
Q1 | $16K | Buy |
+1,788
| New | +$16.8K | ﹤0.01% | 8455 |
|
|
2021
Q4 | – | Sell |
-42,122
| Closed | -$469K | – | 10765 |
|
|
2021
Q3 | $416K | Buy |
42,122
+12,450
| +42% | +$127K | ﹤0.01% | 4376 |
|
|
2021
Q2 | $286K | Sell |
29,672
-125,105
| -81% | -$1.22M | ﹤0.01% | 5057 |
|
|
2021
Q1 | $1.53M | Buy |
154,777
+113,246
| +273% | +$1.75M | ﹤0.01% | 1919 |
|
|
2020
Q4 | $958K | Buy |
41,531
+8,923
| +27% | +$182K | ﹤0.01% | 2615 |
|
|
2020
Q3 | $460K | Sell |
32,608
-55,465
| -63% | -$808K | ﹤0.01% | 3107 |
|
|
2020
Q2 | $1.33M | Buy |
88,073
+65,695
| +294% | +$801K | ﹤0.01% | 1873 |
|
|
2020
Q1 | $206K | Buy |
22,378
+11,706
| +110% | +$111K | ﹤0.01% | 3548 |
|
|
2019
Q4 | $103K | Buy |
10,672
+2,968
| +39% | +$27.2K | ﹤0.01% | 4488 |
|
|
2019
Q3 | $61K | Sell |
7,704
-21,785
| -74% | -$236K | ﹤0.01% | 4816 |
|
|
2019
Q2 | $368K | Buy |
+29,489
| New | +$374K | ﹤0.01% | 2880 |
|
|
2019
Q1 | – | Sell |
-9,524
| Closed | -$116K | – | 7325 |
|
|
2018
Q4 | $91K | Buy |
9,524
+8,124
| +580% | +$89.3K | ﹤0.01% | 3937 |
|
|
2018
Q3 | $16K | Buy |
+1,400
| New | +$19.6K | ﹤0.01% | 6124 |
|
|
2017
Q4 | – | Sell |
-40,336
| Closed | -$554K | – | 6182 |
|
|
2017
Q3 | $608K | Sell |
40,336
-11,242
| -22% | -$149K | 0.02% | 572 |
|
|
2017
Q2 | $519K | Buy |
51,578
+21,447
| +71% | +$173K | 0.02% | 633 |
|
|
2017
Q1 | $214K | Buy |
+30,131
| New | +$191K | 0.01% | 1169 |
|
|
2016
Q4 | – | Sell |
-24,954
| Closed | -$173K | – | 6037 |
|
|
2016
Q3 | $184K | Buy |
+24,954
| New | +$169K | 0.01% | 1095 |
|
|
2016
Q1 | – | Sell |
-14,377
| Closed | -$102K | – | 5792 |
|
|
2015
Q4 | $139K | Sell |
14,377
-21,970
| -60% | -$198K | 0.01% | 1126 |
|
|
2015
Q3 | $508K | Buy |
36,347
+26,188
| +258% | +$411K | 0.04% | 440 |
|
|
2015
Q2 | $143K | Sell |
10,159
-31,842
| -76% | -$383K | 0.01% | 983 |
|
|
2015
Q1 | $456K | Buy |
42,001
+28,561
| +213% | +$252K | 0.05% | 353 |
|
|
2014
Q4 | $112K | Buy |
+13,440
| New | +$92.2K | 0.01% | 874 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Simplex Trading's FOLD Position: Q1 2026 in Review
Simplex Trading sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 18,857 shares — an estimated $270K sold.
Simplex Trading first reported a position in FOLD in Q4 2014 and held it in 32 quarters. The position peaked at $3.58M in Q4 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Simplex Trading reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 18,857 Amicus Therapeutics shares in Q1 2026, an estimated $270K.
- Simplex Trading first reported a position in Amicus Therapeutics in Q4 2014 and held it in 32 quarters.
- Simplex Trading's Amicus Therapeutics position peaked at $3.58M in Q4 2023.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.